Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol for renal protection during partial nephrectomy
NCT01606787Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2012
- Primary completion
- Feb 2018
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Bronchitol in renal ischemia-reperfusion injury, sponsored by Memorial Sloan Kettering Cancer Center. Started May 2012; status: completed.
02
Drugs
Bronchitol
03
Conditions
renal ischemia-reperfusion injury
Beyond the preview
Go deeper on NCT01606787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606787.